ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BNTXBusiness Wire • 01/16/24
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product CandidatesPRNewsWire • 01/10/24
BioNTech SE (BNTX) 42nd Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/09/24
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/09/24
BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial CancerGlobeNewsWire • 12/21/23
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in RwandaGlobeNewsWire • 12/18/23
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024The Motley Fool • 12/18/23
Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion DealSeeking Alpha • 11/12/23
BioNTech Posts a Profit, While Cutting Its Full-Year COVID Vaccine Sales OutlookInvestopedia • 11/06/23
Tesla, Organigram, BioNTech, Dish, Bumble, FreshPet, Berkshire Hathaway – Stocks on the moveProactive Investors • 11/06/23